Intrinsic Value of S&P & Nasdaq Contact Us

Menicon Co Ltd MECNY OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
70/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Menicon Co Ltd (MECNY) trades at a trailing P/E of 20.5. Trailing earnings yield is 4.87%. PEG 0.81 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (75/100, Pass) — P/E is below market average (20.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.81); earnings yield beats bond yields (4.87%).
  • PEG Ratio 0.81 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 4.87% — roughly competitive with bond yields (~4.3%), moderate risk-reward.

Overall SharesGrow Score: 68/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
70/100
SG Score
View full scorecard →
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
PAST
100/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
MOAT
90/100
→ Income
~
GROWTH
40/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — MECNY

Valuation Multiples
P/E (TTM)20.5
Forward P/EN/A
PEG Ratio0.81
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.95
EV/EBITDA0.0
Per Share Data
EPS (TTM)$4.32
Book Value / Share$0.00
Revenue / Share$93.41
FCF / Share$0.00
Yields & Fair Value
Earnings Yield4.87%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2021 $4.52 $86.21B $5.95B 6.9%
2022 $4.93 $100.17B $6.48B 6.5%
2023 $5.59 $110.19B $7.38B 6.7%
2024 $3.45 $116.19B $4.54B 3.9%
2025 $4.32 $121.49B $5.62B 4.6%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message